Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
Trial record 45 of 232 for:    warfarin AND International

The Secondary Prevention of Nonvalvular Atrial Fibrillation Patients With an Initial Cardioembolic Stroke (CE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02181361
Recruitment Status : Completed
First Posted : July 3, 2014
Last Update Posted : December 16, 2019
Sponsor:
Collaborators:
The Third Hospital of PLA
Hanzhong Central Hospital
Xianyang 215 hospital
Yulin Second Hospital
Affiliated Hospital of Yan'an University
Baoji Central Hospital
Ankang Central Hospital
Baoji People's Hospital
Xi'an Central Hospital
Yan'an people's Hospital
451 Hospital
Shangluo Central Hospital
Shaanxi people's Hospital
Central Hospital of China Railway 20th Bureau
Xianyang Central Hospital
Xi'an Ninth Hospital
Shangluo Second People's Hospital
Information provided by (Responsible Party):
Xijing Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2016
Actual Study Completion Date : October 2018